Navigating Global Vaccine Investments

The chapter explores the financial risks of countries investing in multiple vaccine candidates with low success rates, shedding light on vaccine nationalism and concerns over equitable global distribution. It delves into the dynamics of vaccine purchasing consortia, challenges faced by pharmaceutical companies, and the lack of centralized regulation in vaccine distribution. Discussions also revolve around the complexities of producing vaccines during the pandemic, emphasizing the global demand, national priorities, and the timeline for achieving global vaccination.